March 12, 2013 — Brit Systems announced that Novation, the healthcare supply chain expertise and contracting company for VHA, has awarded the company a three-year contract with the potential for two expansion years. The contract starts May 1, 2013.

March 12, 2013 — EDAP TMS SA announced that the U.S. Food and Drug Administration (FDA) has provided a positive administrative acceptance review notification for the company's premarket approval (PMA) application for its Ablatherm integrated imaging HIFU (high-intensity focused ultrasound) device for treatment of low-risk, localized prostate cancer.

Contrast Agents Mayo Clinic Clinical Study Kidney Injury

Many physicians have long believed that the use of intravenous contrast agents for computed tomography (CT) scans can cause acute kidney injury. New Mayo Clinic research questions the strength of the causal link between the two. The findings from two tandem studies are published online in the journal Radiology.

March 11, 2013 — HealthHelp announced it will launch in select markets in May its MedTree QDS, a transparent clinical decision support (CDS) system that allows providers to self-govern the ordering process and receive approval for a test or procedure in less than one minute.

March 11, 2013 — Accelarad announced the selection of its medical imaging solution by Hospital for Special Surgery (HSS) to improve medical image sharing and care coordination with referring physicians anywhere in the world.

Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared its Artis Q and Artis Q.zen angiography system families, which feature revolutionary new X-ray tube and detector technology designed to improve minimally invasive therapy of diseases such as coronary artery disease (CAD), stroke and cancer. The new X-ray tube in both the Artis Q and Artis Q.zen can help physicians identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this X-ray source with a new detector technology that supports interventional imaging in ultra-low-dose ranges to patients, doctors and medical staff — particularly during longer interventions. With the Artis Q and Artis Q.zen system families, Siemens Healthcare again demonstrates its innovative strength and market competitiveness — key components of its Agenda 2013 two-year global Sector initiative.

 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now